miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis
Authors:
- Nathalia Garrido-TorresNGNathalia Garrido-Torres
- Karem Guzmán-TorresKGKarem Guzmán-Torres
- Susana García-CerroSusana García-Cerro
- Gladys Pinilla BermúdezGBGladys Pinilla Bermúdez
- Claudia Cruz-BaqueroCCClaudia Cruz-Baquero
- Hansel OchoaHOHansel Ochoa
- Diego García-GonzálezDGDiego García-González
- Manuel Canal-RiveroMCManuel Canal-Rivero
- Benedicto Crespo-FacorroBCBenedicto Crespo-Facorro
- Miguel Ruiz-VeguillaMRMiguel Ruiz-Veguilla
Open Access
- 3 February 2023
- journal article
- review article
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 33 (9) , 2957-2990
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with complex clinical manifestations that arise between 18 and 36 months of age. Social interaction deficiencies, a restricted range of interests, and repetitive stereotyped behaviors are characteristics which are sometimes difficult to detect early. Several studies show that microRNAs (miRs/miRNAs) are strongly implicated in the development of the disorder and affect the expression of genes related to different neurological pathways involved in ASD. The present systematic review and meta-analysis addresses the current status of miRNA studies in different body fluids and the most frequently dysregulated miRNAs in patients with ASD. We used a combined approach to summarize miRNA fold changes in different studies using the mean values. In addition, we summarized p values for differential miRNA expression using the Fisher method. Our literature search yielded a total of 133 relevant articles, 27 of which were selected for qualitative analysis based on the inclusion and exclusion criteria, and 16 studies evaluating miRNAs whose data were completely reported were ultimately included in the meta-analysis. The most frequently dysregulated miRNAs across the analyzed studies were miR-451a, miR-144-3p, miR-23b, miR-106b, miR150-5p, miR320a, miR92a-2-5p, and miR486-3p. Among the most dysregulated miRNAs in individuals with ASD, miR-451a is the most relevant to clinical practice and is associated with impaired social interaction. Other miRNAs, including miR19a-3p, miR-494, miR-142-3p, miR-3687, and miR-27a-3p, are differentially expressed in various tissues and body fluids of patients with ASD. Therefore, all these miRNAs can be considered candidates for ASD biomarkers. Saliva may be the optimal biological fluid for miRNA measurements, because it is easy to collect from children compared to other biological fluids.Keywords
Funding Information
- Instituto de Salud Carlos III (CM20/00015)
- Universidad de Sevilla
This publication has 54 references indexed in Scilit:
- Genetic variation in the oxytocin receptor (OXTR) gene is associated with Asperger SyndromeMolecular Autism, 2014
- Serum microRNA profiles in children with autismMolecular Autism, 2014
- Validation of the Modified Checklist for Autism in Toddlers, Revised With Follow-up (M-CHAT-R/F)Pediatrics, 2013
- Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicineNature Reviews Neuroscience, 2011
- Gene and miRNA expression profiles in autism spectrum disordersBrain Research, 2011
- The MicroRNA Spectrum in 12 Body FluidsClinical Chemistry, 2010
- Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell linesGenome Medicine, 2010
- Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autismAutism Research, 2008
- Model of autism: increased ratio of excitation/inhibition in key neural systemsGenes, Brain and Behavior, 2003
- Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disordersJournal of Autism and Developmental Disorders, 1994